• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX AFX2; BIFURCATED STENT GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX AFX2; BIFURCATED STENT GRAFT Back to Search Results
Model Number BEA28-90/I16-30
Device Problem Material Puncture/Hole (1504)
Event Date 03/26/2024
Event Type  Injury  
Event Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with implant of an afx2 bifurcated stent graft and an afx vela suprarenal.Approximately five and a half (5.5) years post initial procedure, the stent grafts were explanted on (b)(6) 2024 due to a type iiib endoleak after which vessel replacement was performed.The final patient status is unknown.The explanted stent graft will be returned for evaluation.
 
Manufacturer Narrative
The bifurcated stent graft will be returned for evaluation.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.Device iteration is afx2.
 
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.Endologix conducted a comprehensive assessment of the returned afx2 bifurcated stent graft.The device was securely packaged in a box and transported in a biohazard containment bag.Upon inspection, traces of blood and tissue residue were observed on the device.To ensure safety, the device underwent a thorough decontamination process to eliminate any potential contaminants.A visual inspection of the afx2 bifurcated stent graft revealed no punctures or tears.There were no significant findings from the inspection of the afx2 bifurcated stent graft explant.As no visible punctures or tears were identified, endologix cannot confirm the reported event of an endoleak type iiib.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows the type iiib endoleak and surgical conversion with explant are confirmed.This is consistent with the reported adverse event/incident.Device, user, procedure or anatomy relatedness of this complaint could not be determined.Procedure related harms could not be determined.The final patient status was not reported.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Device iteration is afx2.Corrections: d9: device available for eval - updated.G3: awareness date ¿ updated.H3: device evaluated by manufacturer - updated.H3: device returned to manufacturer for evaluation - updated.H6: investigation finding codes - remove code 3233.H6: investigation conclusion codes - remove code 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AFX2
Type of Device
BIFURCATED STENT GRAFT
Manufacturer (Section D)
ENDOLOGIX
2 musick
irvine CA 92618
Manufacturer (Section G)
ENDOLOGIX
2 musick
,
irvine CA 92618
Manufacturer Contact
gary kirchgater
2 musick
,
irvine, CA 92618
8009832284
MDR Report Key19121996
MDR Text Key340339202
Report Number3011063223-2024-00059
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00818009014597
UDI-Public(01)00818009014597(17)190314
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Distributor
Reporter Occupation Physician
Remedial Action Other
Type of Report Initial
Report Date 03/28/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/14/2020
Device Model NumberBEA28-90/I16-30
Device Lot Number1822112001
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/28/2024
Initial Date FDA Received04/16/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/11/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-0007-2019
Patient Sequence Number1
Treatment
AFX VELA SUPRARENAL: LOT # 1744717024
Patient Outcome(s) Required Intervention;
Patient Age81 YR
Patient SexMale
-
-